Our understanding of the p53 pathway in bladder cancer derives largely from hospital-based and retrospective studies that have captured advanced stage patients undergoing surgery for their disease (Spruck et al, 1994; Silverman et al, 1996; Smith et al, 2003; Soloway et al, 2003). This evidence concerns the gene TP53 and urinary bladder carcinoma.